REQUEST A DEMO
Total
USD $0.00
Search more companies

Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures (Romania)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures Profile Updated: September 13, 2021
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English Download a sample report

Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures is an enterprise in Romania, with the main office in TARGU MURES. The company operates in the Pharmaceutical and Medicine Manufacturing industry. The enterprise was incorporated on November 24, 2010. There are currently 2 (2016) people employed by Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures. During that time, Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures’s total assets decreased by 0.11%.

Headquarters
Strada Iuliu Maniu Nr. 8
TARGU MURES; Mures; Postal Code: 540028

Contact Details: Purchase the Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures report to view the information.

Basic Information
Total Employees:
Purchase the Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures report to view the information.
Outstanding Shares:
Purchase the Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures report to view the information.
Ratings:
Purchase the Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures report to view the information.
Incorporation Date:
November 24, 2010
Key Executives
Purchase this report to view the information.
Empowered representative
Ownership Details
Subsidiaries
Company Performance
Financial values in the chart are available after Corax-Bioner Biotechnologiai SA Budapesta Sucursala Mures report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
44.97%
EBITDA
21.26%
Net Profit (Loss) for the Period
43.32%
Total assets
-0.11%
Total equity
-1.68%
Return on Equity (ROE)
-1.31%
Quick Ratio
-0%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?